Alaunos Therapeutics, Inc. Deferred Compensation Arrangement with Individual, Shares Issued
Alaunos Therapeutics, Inc. (TCRT) reported Deferred Compensation Arrangement with Individual, Shares Issued of 446.43 thousand shares for the 0-month period ending 2019-01-06, per its 10-Q filed 2020-11-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued · last filed 2020-11-05
- 2019-01-06: Deferred Compensation Arrangement with Individual, Shares Issued 0 month 446.43K shares.
| Period end | Deferred Compensation Arrangement with Individual, Shares Issued 0 month |
|---|---|
| 2019-01-06 | 446.43K shares 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |